Milad Rouhimoghadam
Department of Cell and Molecular Biology, School of Biology, College of Science, University of Tehran, IranTehran, Iran
Abstracts, Milad Rouhimoghadam [Author]
-
Tamoxifen is a putative substrate that affect the ubiquitin-proteasome pathway to the therapy of breast cancer
Cancer; Prevention, Diagnosis and TreatmentTamoxifen, a synthetic triphenyl-ethylene compound, is a member of a class of anticancer drugs known as selective estrog...Read more